IL6 and neoplasm: Serum interleukin 6 (IL-6) decreased the expression of PTPRO by activating signal transducer and activator of transcription 3 (STAT3)/c-MYC/miR-25-3p axis, leading to PD-L1-induced immunosuppression to promote tumor growth (24).